BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 16954555)

  • 1. Dosimetry in Peptide radionuclide receptor therapy: a review.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides.
    Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candidates for peptide receptor radiotherapy today and in the future.
    Reubi JC; Mäcke HR; Krenning EP
    J Nucl Med; 2005 Jan; 46 Suppl 1():67S-75S. PubMed ID: 15653654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent issues on dosimetry and radiobiology for peptide receptor radionuclide therapy.
    Cremonesi M; Ferrari M; Di Dia A; Botta F; De Cicco C; Bodei L; Paganelli G
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):155-67. PubMed ID: 21386788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor control probability for tumor therapy with beta radionuclide interstitial injection.
    Chen Y; Geng J; Tian J; He Y; Chen S
    Biomed Mater Eng; 2004; 14(3):333-5. PubMed ID: 15299245
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
    Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
    J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.
    Pauwels S; Barone R; Walrand S; Borson-Chazot F; Valkema R; Kvols LK; Krenning EP; Jamar F
    J Nucl Med; 2005 Jan; 46 Suppl 1():92S-8S. PubMed ID: 15653657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical and clinical studies of peptide receptor radionuclide therapy.
    Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M
    Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry of internal emitters.
    Sgouros G
    J Nucl Med; 2005 Jan; 46 Suppl 1():18S-27S. PubMed ID: 15653648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.
    Wessels BW; Konijnenberg MW; Dale RG; Breitz HB; Cremonesi M; Meredith RF; Green AJ; Bouchet LG; Brill AB; Bolch WE; Sgouros G; Thomas SR
    J Nucl Med; 2008 Nov; 49(11):1884-99. PubMed ID: 18927342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the magic bullet to an effective therapy: the peptide experience.
    Mansi L
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1393-8. PubMed ID: 15351914
    [No Abstract]   [Full Text] [Related]  

  • 12. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorbed fractions in ellipsoidal volumes for beta(-) radionuclides employed in internal radiotherapy.
    Amato E; Lizio D; Baldari S
    Phys Med Biol; 2009 Jul; 54(13):4171-80. PubMed ID: 19521004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-factor calculations for mouse models using Monte-Carlo simulations.
    Bitar A; Lisbona A; Bardiès M
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):343-51. PubMed ID: 17538523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment planning in molecular radiotherapy.
    Glatting G; Bardiès M; Lassmann M
    Z Med Phys; 2013 Dec; 23(4):262-9. PubMed ID: 23597414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of dose with toxicity and tumour response to
    Cremonesi M; Ferrari ME; Bodei L; Chiesa C; Sarnelli A; Garibaldi C; Pacilio M; Strigari L; Summers PE; Orecchia R; Grana CM; Botta F
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2426-2441. PubMed ID: 29785514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine anatomic phantom for preclinical dosimetry in internal emitter therapy.
    Padilla L; Lee C; Milner R; Shahlaee A; Bolch WE
    J Nucl Med; 2008 Mar; 49(3):446-52. PubMed ID: 18287264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetry of beta nuclide filled balloon catheter in endovascular brachytherapy.
    Chen Y; Geng J; Tian J; Yin D; Chen S
    Biomed Mater Eng; 2004; 14(3):337-9. PubMed ID: 15299246
    [No Abstract]   [Full Text] [Related]  

  • 19. Overview of dosimetry for Systemic Targeted Radionuclide Therapy (STaRT).
    Wessels BW; Syh JH; Meredith RF
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S39-45. PubMed ID: 16979438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of ankylosing spondylitis with 224Ra-radium chloride: dosimetry and risk considerations.
    Lassmann M; Nosske D; Reiners C
    Radiat Environ Biophys; 2002 Sep; 41(3):173-8. PubMed ID: 12373325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.